COVID-19 Pandemic Review

COVID-19 Pandemic Seminar CME / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 1 (CVD19P1) Topics Include:  Laboratory Tests in Suspected COVID-19 Patients, PPE, Olfactory Loss, Investigating Antivirals, Social Isolation and the Elderly, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
Full Course Price:
Short Course:
Short Course Price:
Available in Audio format.

Course Topics

Coronavirus Disease 2019 (COVID-19)

Identify signs and symptoms of COVID-19; Order and interpret laboratory tests in patients with suspected COVID-19; Recognize comorbidities that increase the risk for acute respiratory distress syndrome in patients with COVID-19; Elaborate on the use of antiviral drugs in patients with COVID-19; Prevent transmission of COVID-19 in the health care environment.

Coronavirus/Whole Blood as a Resuscitation Strategy

Elaborate on the biology of the SARS-CoV-2 coronavirus; Recognize clinical features of infection with SARS-CoV-2; Follow recommendations for personal protective equipment when caring for patients with coronavirus disease 2019; Cite currently available data on use of whole blood for transfusion in trauma patients; Consider the safety profile of whole blood when developing protocols for trauma-related resuscitation.


Identify types and causes of olfactory disorders; Perform clinical evaluation of patients with olfactory disorders; Evaluate patients with postviral olfactory loss associated with coronavirus disease 2019 (COVID-19); Develop treatment strategies for patients with olfactory disorders; Implement quality improvement measures to optimize care of pediatric patients with tracheostomies

COVID-19 Updates

Recognize common and uncommon manifestations of coronavirus disease 2019; Interpret laboratory findings in a patient with suspected coronavirus disease 2019; Summarize findings of recent and ongoing randomized, controlled trials investigating antivirals and other agents for treatment of coronavirus disease 2019 Trace the origins and spread of the epidemic of coronavirus disease 2019; Counsel a patient who asks about the efficacy of masks for prevention of coronavirus disease 2019.


Geriatric Patients and COVID-19

Identify challenges in effective advance care planning; Facilitate completion of advance care planning in elderly patients; Recognize signs of loneliness and social isolation in older patients; Employ measures to ameliorate loneliness and social isolation in elderly patients; Adapt performance to optimize the value of telemedicine visits for older adults.


Highlights from the 4th Annual Innovations in Cardiovascular Diagnosis and Therapy

Diagnose and treat the thromboembolic complications associated with COVID-19 virus infection; Recommend medications for, and duration of, antiplatelet therapy; List trials of antiplatelet therapies and explain their significance; Explain the role of sodium-glucose cotransporter-2 inhibitors and vericiguat in the treatment of HF; Implement cardiopulmonary stress testing to assess appropriateness of heart transplantation for a patient with advanced heart disease.

COVID-19: Treatments and Vaccines

Develop an overall treatment strategy for hospitalized patients with COVID-19; List all the effective antiviral and immunomodulatory therapies for patients infected with COVID-19; Explain the current landscape of vaccine development for COVID-19; Cite guideline recommendations of the National Institutes of Health and Infectious Disease Society of America regarding therapies for COVID-19; Optimize use of immunomodulators during the immuneinflammatory phase of the disease.


COVID-19 Update

Counsel patients about activities that place them at highest risk for contracting COVID-19; Identify patients who are at risk for severe outcomes of COVID-19 based on comorbid conditions; Recommend appropriate isolation periods for asymptomatic and symptomatic patients with positive COVID-19 test results; Predict risk for severe outcomes among patients with different types of rheumatic diseases; Manage the use of disease-modifying antirheumatic drugs in patients who test positive for COVID-19.


Hospital Readmissions/Telemedicine

Identify patients who are at high risk for hospital readmission; Develop strategies to reduce hospital readmissions; Utilize hospital and community resources to create personalized discharge plans that reduce hospital readmission; Review recent regulatory and billing changes in telemedicine that occurred after the start of the COVID-19 pandemic; Create strategies for incorporating telemedicine into clinical practice.

Highlights from State of the Art: Kidney and Pancreas Transplantation

Recognize the importance of telemedicine for the delivery of health care during and after the COVID-19 pandemic; Optimize the selection and management of living organ donors through telemedicine; Identify social determinants of health for COVID-19 and its impact on transplant patients; Describe the demographics of the COVID-19 pandemic's effect on the general and transplant populations; Recognize the financial and mental health impacts of COVID-19, particularly in the kidney transplant population.


Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Internal MedicineOncologyPediatricsFamily PracticePsychology, and Psychiatry

If you have taken the current Controlled Substance CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.


video (mp4)